Title : Metformin Synergizes with BCL-XL/BCL-2 Inhibitor ABT-263 to Induce Apoptosis Specifically in p53-Defective Cancer Cells.

Pub. Date : 2017 Sep

PMID : 28533436






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Metformin has shown anti-neoplastic efficiency partially through suppressing mTORC1. Metformin CREB regulated transcription coactivator 1 Mus musculus
2 Mechanistic studies revealed that metformin sensitized ABT-263 via attenuating mTORC1-mediated cap-dependent translation of MCL-1 and survivin and weakening internal ribosome entry site (IRES)-dependent translation of XIAP Meanwhile, ABT-263 sensitized metformin through disrupting the BCL-XL/BIM complex. Metformin CREB regulated transcription coactivator 1 Mus musculus